Terpinen-4-ol and alpha-terpineol (tea tree oil components) inhibit the production of IL-1β, IL-6 and IL-10 on human macrophages

Inflammation Research

Volumn 63, Issue 9, 2014, Pages 769-778

  Nogueira, M N M ^a,b   Aquino, S G ^a   Rossa, C ^a   Spolidorio, D M P ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b NONE   (Brazil)

Author keywords

Cytokines; Inflammation; Macrophages; Tea tree oil

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE P38; TEA TREE OIL; TERPINEN 4 OL; TERPINEOL; TUMOR NECROSIS FACTOR ALPHA; ALPHA-TERPINEOL; ANTIINFLAMMATORY AGENT; CYCLOHEXENE DERIVATIVE; CYTOKINE; MITOGEN ACTIVATED PROTEIN KINASE; TERPENE; TERPINENOL-4; TLR2 PROTEIN, HUMAN; TLR4 PROTEIN, HUMAN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOMODULATION; MACROPHAGE; MELALEUCA; SIGNAL TRANSDUCTION; U937 CELL LINE; WESTERN BLOTTING; DRUG EFFECTS; IMMUNOLOGY;

ANTI-INFLAMMATORY AGENTS; CYCLOHEXENES; CYTOKINES; HUMANS; LIPOPOLYSACCHARIDES; MACROPHAGES; MITOGEN-ACTIVATED PROTEIN KINASES; MONOTERPENES; NF-KAPPA B; SIGNAL TRANSDUCTION; TEA TREE OIL; TERPENES; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; U937 CELLS;

EID: 84906214200     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-014-0749-x     Document Type: Article

References (34)

1. Carson CF, Hammer KA, Riley TV. Melaleuca alternifolia (Tea Tree) Oil: a review of antimicrobial and other medicinal properties. Clin Microbiol Rev. 2006;19:50-62.
2. Cox SD, Mann CM, Markham JL. Interactions between components of the essential oil of Melaleuca alternifolia. J Appl Microbiol. 2001;91:492-7.
3. Keszei A, Hassan Y, Foley JW. A biochemical interpretation of terpene chemo types in Melaleuca alternifolia. J Chem Ecol. 2010;36:652-61.
4. Shelton D, Zabaras D, Chohan S, Wyllie G, Baverstock P, Leach D, Henry R. Isolation and partial characterisation of a putative monoterpene synthase from Melaleuca alternifolia. Plant Physiol Biochem. 2004;42:875-82.
5. Catalán A, Pacheco JG, Martínez A, Mondaca MA. In vitro and in vivo activity of Melaleuca alternifolia mixed with tissue conditioner on Candida albicans. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;105:327-32.
6. Kwiecinski J, Eick S, Wójcik K. Effects of tea tree (Melaleuca alternifolia) oil on Staphylococcus aureus in biofilms and stationary growth phase. Int J Antimicrob Agents. 2009;33:343-7.
7. Minami M, Kita M, Nakaya T, Yamamoto T, Kuriyama H, Imanishi J, Minami M. The inhibitory effect of essential oils on herpes simplex virus type-1 replication in vitro. Microbiol Immunol. 2003;47:681-4.
8. Wilkinson JM, Cavanagh HMA. Antibacterial activity of essential oils from Australian native plants. Phytother Res. 2005;19:643-6.
9. Greay SJ, Ireland DJ, Kissick HTA, Levy MW, Beilharz TV, Riley CF, Carson CF. Induction of necrosis and cell cycle arrest in murine cancer cell lines by Melaleuca alternifolia (tea tree) oil and terpinen-4-ol. Cancer Chemother Pharmacol. 2010;65:877-88.
10. Hart PH, Brand C, Carson CF, Riley TV, Prager RH, Finlay-Jones JJ. Terpinen-4-ol, the main component of the essential oil of Melaleuca alternifolia (tea tree oil), suppresses inflammatory mediator production by activated human monocytes. Inflamm Res. 2000;49:619-26.
11. Bassett IB, Pannowitz DL, Barnetson RS. A comparative study of tea-tree oil versus benzoylperoxide in the treatment of acne. Med J Aust. 1990;153:455-8.
12. Carson CF, Ashton L, Dry L, Smith DW, Riley TV. Melaleuca alternifolia (tea tree) oil gel (6%) for the treatment of recurrent herpes labialis. J Antimicrob Chemother. 2001;48:450-1.
13. Soukoulis S, Hirsch R. The effects of a tea tree oil-containing gel on plaque and chronic gingivitis. Aust Dent J. 2004;49:78-83.
14. Khalil Z, Pearce AL, Satkunanathan N, Storer E, Finlay-Jones JJ, Hart PH. Regulation of wheal and flare by tea tree oil: complementary human and rodent studies. J Invest Dermatol. 2004;123:683-90.
15. Caldefie-Chézet F, Fusillier C, Jarde T, Laroye H, Damez M, Vasson MP, Guillot J. Potential anti-inflammatory effects of Melaleuca alternifolia essential oil on human peripheral blood leukocytes. Phytother Res. 2006;20:364-70.
16. Brand C, Townley SL, Finlay-Jones JJ, Hart PH. Tea tree oil reduces histamine-induced edema in murine ears. Inflamm Res. 2002;51:283-9.
17. Abe S, Maruyama N, Hayama K, Ishibashi H, Inoue S, Oshima H, Yamaguchi H. Suppression of tumor necrosis factor-alpha-induced neutrophil adherence responses by essential oils. Mediators Inflamm. 2003;12:323-8.
18. Eskan MA, Rose BG, Benakanakere MR, Zeng Q, Fujioka D, Martin MH, Lee MJ, Kinane DF. TLR4 and S1P receptors cooperate to enhance inflammatory cytokine production in human gingival epithelial cells. Eur J Immunol. 2008;38:1138-47.
19. Souza JA, Rossa C Jr, Garlet GP, Nogueira AV, Cirelli JA. Modulation of host cell signaling pathways as a therapeutic approach in periodontal disease. J Appl Oral Sci. 2012;20:128-38.
20. Luvizotto-Santos R, Cordeiro PJM, Vieira EM. Analysis of methyl parathion in tilapia filets using a simple solid phase extraction clean-up and GC-NPD. Braz J Food Technol. 2009;7:158-61.
21. Sciarronea D, Ragonesea C, Carnovalea C, Pipernoa A, Dugoa P, Dugoa G, Mondello L. Evaluation of tea tree oil quality and ascaridole: a deep study by means of chiral and multi heart-cuts multidimensional gas chromatography system coupled to mass spectrometry detection. J Chromatogr. 2010;1217:6422-7.
22. Kikkert R, Laine ML, Aarden LA, Van Winkelhoff AJ. Activation of toll-like receptors 2 and 4 by gram-negative periodontal bacteria. Oral Microbiol Immunol. 2007;22:145-51.
23. Rovera G, Santoli D, Damsky C. Human promyelocytic leukemia cells in culture differentiate into macrophage-like cells when treated with a phorbol diester. Proc Nati Acad Sci. 1979;76:2779-83.
24. Medzhitov R. Toll like receptors and innate immunity. Nat Rev Immunol. 2001;1:135-45.
25. Feldman M, Grenier D. Cranberry proanthocyanidins act in synergy with licochalcone A to reduce Porphyromonas gingivalis growth and virulence properties, and to suppress cytokine secretion by macrophages. J Appl Microbiol. 2012;113:438-47.
26. Bradford MM. Rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-54.
27. Brand C, Ferrante A, Prager RH, Riley TV, Carson CF, Finlay-Jones JJ, Hart PH. The water-soluble components of the essential oil of Melaleuca Alternifólia (tea tree oil) suppress the production of superoxide by human monocytes, but not neutrophils, activated in vitro. Inflamm Res. 2001;50:213-9.
28. Jain S, Darveau RP. Contribution of Porphyromonas gingivalis lipopolysaccharide to periodontitis. Periodontology. 2000;2010(54):53-70.
29. Shirakawa F, Mizel SB. In vitro activation and nuclear translocation of NF-kappaB catalyzed by cyclic AMP-dependent protein kinase and protein kinase C. Mol Cell Biol. 1989;9:2424-30.
30. Traenckner EB, Pahl HL, Henkel T, Schmidt KN, Wilk S. Baeuerle, P.A. Phosphorylation of human IkappaB-alpha on serines 32 and 36 controls IkappaB-alpha proteolysis and NF-kappaB activation in response to diverse stimuli. EMBO J. 1995;14:2876-83.
31. Lu YC, Yeh WC, Ohashi OS. LPS/TLR4 signal transduction pathway. Cytokine. 2008;42:145-51.
32. Brand C, Grimbaldeston MA, Gam-ble JR, Drew J, Finlay-Jones JJ, Hart PH. Tea tree oil reduces the swelling associated with the efferent phase of a contact hypersensitivity response. Inflamm Res. 2002;51:236-44.
33. Pearce AL, Finlay-Jones JJ, Hart PH. Reduction of nickel-induced contact hypersensitivity reactions by topical tea tree oil in humans. Inflamm Res. 2005;54:22-30.
34. Koh KJ, Earce AL, Marsh-man G, Finlay-Jones JJ, Hart PH. Tea tree oil reduces histamine-induced skin inflammation. Br J Dermatol. 2002;147:1212-7.